关键词:
COVID
Child
Omicron
Clinical severity
摘要:
Objectives This multicentre cohort study describes Aotearoa New Zealand (NZ) children hospitalised during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods Children under 16 years of age, hospitalised for more than six hours with COVID-19 across NZ January to May 2022 were included. Admissions for all Māori and Pacific, and every second non-Maori non-Pacific (NMNP) child were selected to support equal explanatory power for ethnic grouping. Attribution of hospital admission, demography, clinical presentation, comorbidity, treatment and outcome data were collected. Results Of 444 hospitalisations of children positive for COVID-19, 292 (65·5%) from 290 children were considered admissions attributable to COVID-19. Of these admissions, 126 (43·4%) were aged under one; and 118 (40·7%), 99 (34·1%) and 87 (30·0%) were in children of Māori, Pacific and NMNP ethnicity, respectively. Underlying respiratory disease was the most common co-morbidity, present in 22 children (7·6%); 16 children (5·5%) were immunosuppressed. Median length of stay was one day (IQR 0.0-2.0). Four children received antiviral, 69 (24%) antibacterials and 24 (8%) supplemental oxygen. Whilst 8 children required intensive care, there were no deaths. Conclusion Children hospitalised during the first significant wave of SARS-CoV-2 infection in NZ presented with a multi-system viral illness and rarely with severe disease.